Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Relapsed or refractory low-grade or follicular, CD20-positive, B-cell Non-Hodgkin Lymphoma
Dose: Intravenous infusion – 375 mg/m²
Frequency: Once weekly
Duration: 4 to 8 doses
Indication: Retreatment for relapsed or refractory, low-grade or follicular, CD20-positive, B-cell Non-Hodgkin Lymphoma
Dose: Intravenous infusion – 375 mg/m²
Frequency: Once weekly
Duration: 4 doses

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Not applicable – Safety and efficacy not established
Note: Safety and efficacy not established
Administration
  • Given as IV infusion only
  • First dose: start slow, increase gradually
Side Effect

Drug Interaction

Drug NameRisk Factors
Cisplatin
Increased risk of renal toxicity
Live vaccines
Potentially Fatal: May decrease the efficacy of vaccines and increase the risk of infections

Disease Interaction

Disease NameRisk Factors
Type I Hypersensitivity to Murine Proteins
Can cause severe allergic reactions to mouse-derived proteins

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 2-8° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.